about
TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potentialPOSTER COMMUNICATIONSTheoretical and therapeutic considerations for the anxiety disorders.Involvement of the brain noradrenaline system in emotional changes caused by stress in rats.Alcoholism and panic disorder: is the comorbidity more than coincidence?Anxiety disorders through a transcultural perspective: implications for migrants.New approaches to the pharmacological management of generalized anxiety disorder.Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view.Clonidine: understanding its disposition, sites and mechanism of action.Autoreceptors in the central nervous system.Noradrenergic mechanisms in stress and anxiety: II. Clinical studies.The SHR exhibits less "anxiety" but increased sensitivity to the anticonflict effect of clonidine compared to normotensive controls.The relationship of isolated sleep paralysis and panic disorder to hypertension.The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia.Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability.Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers.Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour.The effects of clonidine on the fear-inhibited light reflex.Behavioral and autonomic responses to intermittent social stress: differential protection by clonidine and metoprolol.Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation.
P2860
Q28260961-2D7C14C4-318F-4618-97CD-7359244DDB66Q29031985-020B58F0-1440-41D7-B5B1-C1924C5B9752Q35274922-E68A7AE8-69CC-4418-84D7-733184C73E72Q37595672-8C62B830-49BC-43F6-B1C9-38EEBA5A0BA1Q37915749-6FE7ED48-4FA3-4C5F-BBCB-9F255E56938DQ37978079-DC5FBC96-86B6-405A-A2F3-97DE7F7832FDQ38071131-549BC1BF-8294-4B7E-A869-D9602A1B5F51Q38174210-A4AFBE00-269B-421C-A485-A5FDDA0E284FQ39152727-8505C009-85E8-4500-9D81-24CB9C233D37Q39511474-5DE093B9-1876-48CE-A162-D61C43A729CAQ41045442-0050DADD-EF90-4475-BB3D-75C2A64DCE1EQ41278710-60EFC119-312C-4C41-A77D-DCCC1BE7ADAAQ41435023-36DCF8FA-8F05-4129-B858-62832D194C3CQ42141250-41F9BD9E-8FD4-4707-9C63-E6DEFEFE8102Q44667926-3B2D1DE1-8992-4CA8-8E42-C21B0B2C3B01Q46057293-3B02DE4B-95FE-4898-B709-04E01E107732Q48221695-6A0A981B-15FD-49DE-A189-E291D60B32E7Q49012982-237DB3F0-D18C-4969-8E73-04C515CDC228Q51095352-D9F30D49-CDB8-4DE6-805C-2BCB1349770CQ51130149-F35F260D-6EB8-4105-9F12-ED397AFAFFFFQ53827427-B06F3BF1-8878-4F24-B89D-76813F6864F8
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Effects of clonidine on anxiety disorders.
@ast
Effects of clonidine on anxiety disorders.
@en
Effects of clonidine on anxiety disorders.
@nl
type
label
Effects of clonidine on anxiety disorders.
@ast
Effects of clonidine on anxiety disorders.
@en
Effects of clonidine on anxiety disorders.
@nl
prefLabel
Effects of clonidine on anxiety disorders.
@ast
Effects of clonidine on anxiety disorders.
@en
Effects of clonidine on anxiety disorders.
@nl
P2093
P1433
P1476
Effects of clonidine on anxiety disorders.
@en
P2093
Hoehn-Saric R
Merchant AF
P304
P356
10.1001/ARCHPSYC.1981.01780360094011
P407
P577
1981-11-01T00:00:00Z